Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2008 Dec 23;21(2):155–165. doi: 10.1093/intimm/dxn133

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author 2008. Published by Oxford University Press on behalf of The Japanese Society for Immunology. All rights reserved.

The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press and The Japanese Society for Immunology are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org

PMC Copyright notice

Fig. 4. — Serial [¹⁸F]FHBG micro-PET imaging of T-cell persistence at various anatomical locations in mice treated with combined immunotherapy. (A) Time line of the imaging study. (B) Mice were imaged with micro-PET/CT 60 min after i.v. injection with [¹⁸F]FHBG. Representative 3D micro-PET/CT images of the same mouse on different days are displayed. Red arrows indicate days that mice received gp100_25–33/DC vaccine and high-dose IL-2. A, axillary LN; B, brachial LN; C, cervical LN; T, tumor.